InBios International
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · Washington, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
307 Westlake Ave N Ste 300, Seattle, Was...Phone Number
(206) 344-5821Website
www.inbios.comRevenue
$14.4 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
3
4
1
1
1
1
About InBios International
InBios International, Inc. specializes in the design, development, and manufacturing of high-quality immunodiagnostics for infectious diseases. Their product line includes diagnostic tests for various diseases such as Chagas, Dengue, and COVID-19, aimed at improving health outcomes globally. The company serves clinical laboratories and healthcare providers, focusing on cost-effective and user-friendly solutions. With nearly 25 years of experience, InBios is committed to quality and responsiveness to emerging infectious disease threats.Explore more
InBios International Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is InBios International your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on InBios International recently announced quarterly report
InBios International, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when InBios International launches new products
Congratulate Masked Content for being promoted to Masked Content at InBios International
Check if InBios International has recently received funding, and reach out quickly before it becomes old news!
Click to see if InBios International had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once InBios International has new funding data
Check out if InBios International is spiking on competitors!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to InBios International
Compare insights from companies similar to InBios International, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
InBios International is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
InBios International is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about InBios International.
InBios International financials insights
Gather financial insights about InBios International, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Debt
$1M
2021
Debt
$1M
InBios International Tech Stack
A closer look at the technologies used by InBios International
Most Recent Scoops
Funding
Project
Spending/Investment, Funding
Event
Product Marketing, Events, Training, Sales, Learning & Development, Search, Laboratory Operations, Medical Education & Training, Medical Research, Field /Outside Sales, Clinical Operations, Field Marketing, Healthcare Technology, HR Operations, Operations
Event
will be attending the 2022 AACC Annual Scientific Meeting + Clinical Lab Expo conference as an exhibitor. The event will occur from July 24 to July 28, 2022.
Funding
InBios International has received an SBA PPP loan in the amount of $1,014,108 from Bank of America resulting in the retention of 73 jobs.
Funding
InBios International News & Media
Seattle's InBios Secures BARDA-funded Project Award Valued Over $16M to Enhance Rapid Biothreat Test
InBios International Inc., a leading developer of diagnostics for infectious diseases, announced that it received a project award valued at $16,511,354 to optimize, complete performance validation, and file for FDA clearance(s) for the company's rapid test for melioidosis. Funding will...InBios Receives FDA 510(k) Clearance for COVID-19 POC Antigen Detection Test
InBios International Inc., a leading developer of diagnostic tests for emerging infectious diseases, announced today that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its SCoV-2 Ag Detect Rapid Test. SEATTLE, Sept. 5, 2024 /PRNewswire-PRWeb/ -- With a...InBios Launches an In Vitro Diagnostic Test for Strongyloidiasis Providing Fast Results
InBios International Inc., a leading developer and manufacturer of diagnostic tests for emerging infectious diseases and biothreats, is launching a new in vitro serological ELISA kit for presumptive clinical laboratory diagnosis of Strongyloides infection that offers results in under 75...FDA Grants First Marketing Rights for Anthrax Point-of-Care Test to...
Test can be used by military and healthcare professionals with results in ~20 minutes. (PRWeb March 01, 2023) Read the full story at https://www.prweb.com/releases/2023/3/prweb19198039.htm
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding InBios International
Sign Up For FreeTo access detailed company insights
InBios International, Inc. specializes in the design, development, and manufacturing of high-quality immunodiagnostics for infectious diseases. Their product line includes diagnostic tests for various diseases such as Chagas, Dengue, and COVID-19, aimed at improving health outcomes globally. The company serves clinical laboratories and healthcare p... Read More
